235 related articles for article (PubMed ID: 9360981)
1. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
Cain D; Hutson SM; Wallin R
J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Sane DC; Hutson SM
Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
[TBL] [Abstract][Full Text] [Related]
4. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149
[TBL] [Abstract][Full Text] [Related]
5. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
Cain D; Hutson SM; Wallin R
Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
[TBL] [Abstract][Full Text] [Related]
6. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
Wajih N; Hutson SM; Wallin R
J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of vitamin K epoxide reductase.
Tie JK; Stafford DW
Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
[TBL] [Abstract][Full Text] [Related]
8. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
9. Warfarin and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Hutson SM
Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
[TBL] [Abstract][Full Text] [Related]
10. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL
J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134
[TBL] [Abstract][Full Text] [Related]
11. The potent antioxidant activity of the vitamin K cycle in microsomal lipid peroxidation.
Vervoort LM; Ronden JE; Thijssen HH
Biochem Pharmacol; 1997 Oct; 54(8):871-6. PubMed ID: 9354587
[TBL] [Abstract][Full Text] [Related]
12. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
Wallin R; Martin LF
J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
[TBL] [Abstract][Full Text] [Related]
14. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
15. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
Begent LA; Hill AP; Steventon GB; Hutt AJ; Pallister CJ; Cowell DC
J Pharm Pharmacol; 2001 Apr; 53(4):481-6. PubMed ID: 11341364
[TBL] [Abstract][Full Text] [Related]
16. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
[TBL] [Abstract][Full Text] [Related]
17. Functional study of the vitamin K cycle in mammalian cells.
Tie JK; Jin DY; Straight DL; Stafford DW
Blood; 2011 Mar; 117(10):2967-74. PubMed ID: 21239697
[TBL] [Abstract][Full Text] [Related]
18. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
Lee JJ; Principe LM; Fasco MJ
Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1.
Van Horn WD
Crit Rev Biochem Mol Biol; 2013; 48(4):357-72. PubMed ID: 23631591
[TBL] [Abstract][Full Text] [Related]
20. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
Fasco MJ; Principe LM
J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
